UnitedHealth wins favorable ruling against US fraud case

Reuters
昨天
UnitedHealth wins favorable ruling against US fraud case

By Brendan Pierson

March 4 (Reuters) - A court-appointed special master has found that U.S. authorities do not have evidence to support their billion-dollar fraud case accusing UnitedHealth Group UNH.N of keeping overpayments from the government for patients on its Medicare insurance plans.

The recommendation by Special Master Suzanne Segal on Monday is not a final ruling, but if it is adopted by U.S. District Judge Fernando Olguin, it would end the U.S. Department of Justice's claims against the health insurer.

"After more than a decade of DOJ’s wasteful and expensive challenge to our Medicare Advantage business, the Special Master concluded there was no evidence to support the DOJ’s claims we were overpaid or that we did anything wrong," UnitedHealth said in a statement.

The Justice Department did not immediately respond to a request for comment.

The government claimed in its 2016 lawsuit that UnitedHealth submitted false diagnoses for patients on its government-funded, privately administered Medicare Advantage plans in order to get higher payments. Medicare reimbursements to insurers that administer Medicare Advantage plans are tied to patients' diagnosis codes, with sicker patients getting higher reimbursements.

However, Segal wrote on Monday that the government's case relied on discrepancies between diagnoses submitted by doctors making claims and later determinations by UnitedHealth's coders. She said that did not show that any of the original claims were false, concluding that there "simply was no fraud."

(Reporting by Brendan PiersonEditing by Bill Berkrot)

((646-306-0235))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10